TMO Stock Chart & Fundamental Analysis

Interactive Chart

About Thermo Fisher Scientific

Name

Thermo Fisher Scientific

CEO

Marc N. Casper

Website

www.thermofisher.com

Industry

Healthcare

Year Founded

1956

Employees

125,000

Thermo Fisher Scientific Inc. develops and sells tools and services for research, diagnostics, and biopharma production, operating in the healthcare and Medical - Diagnostics & Research space. On the NYSE under TMO, it generated $44.6 billion of revenue in FY2025.

Analyst Ratings

Consensus Recommendation

Buy5

Hold1

Sell1

Fundamentals & Financials

Revenue (TTM)

$45.1B

Net Income (TTM)

$6.8B

EPS (TTM)

$18.22

ROA (TTM)

6.05%

Current Ratio

1.53

Dividend Yield

0.092%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q1 FY2026	Q4 FY2025	Q3 FY2025
Revenue	$11,005M	$12,215M	$11,122M
Cost of Sales	$6,529M	$7,579M	$6,470M
Gross Profit	$4,476M	$4,636M	$4,652M
Operating Income	$1,863M	$2,302M	$1,943M
Net Income	$1,651M	$1,975M	$1,616M
EPS	$4.44	$5.22	$4.28

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

Thermo Fisher Scientific's Technical Indicators Summary

Thermo Fisher exhibits constructive technicals with multiple momentum measures and moving averages aligned higher. MACD and CCI are bullish and short- to medium-term averages sit below the current price, though the 200‑day average is nearby, creating a mixed longer-term reference. ADX indicates a moderate trend and OBV is positive, implying supportive volume behind the move. Volatility by ATR is subdued. The classic pivot also sits below price as a support reference. Technical takeaway: Strong Buy — momentum and volume underpin the uptrend despite a close 200‑day reference.

Buy

5 signals

Neutral

1 signal

Sell

1 signal

Overall: Bullish71% Bullish signals

Indicator	Value	Signal	Explanation
RSI (14)	66.73	Neutral	RSI (66.73) is neutral.
Stochastic %K (14, 3, 3)	84.88	Sell	Stochastic (84.88) > 80, indicating overbought.
CCI (20)	161.60	Buy	CCI (161.60) > 100, indicating strong upward momentum.
WPR (14)	-7.98	Sell	Williams %R (-7.98) > -20, indicating overbought.
Momentum (10)	61.75	Buy	Momentum (61.75) is positive.
MFI	63.51	Neutral	MFI (63.51) is neutral.
MACD Level (12, 26)	10.87	Buy	Confirmed uptrend: MACD (10.87) is positive and above its signal line (6.12).
Bollinger Bands	$446.93 - $523.78	Neutral	Price is within the bands.
ATR (14)	$14.96 (2.86%)	Neutral	Moderate Volatility (2.86%).
ADX (14)	24.79	Neutral	Weak or consolidating trend (ADX < 25). ADX(24.79), +DI(34.72), -DI(13.64)
OBV	16,617,852	Buy	Bullish volume pressure: OBV is above its 20-day SMA. OBV(16,617,852), 20D-SMA-OBV(9,615,884)
Classic Pivot Point	$512.46	Buy	Price ($523.44) has broken above resistance R1 ($522.04) — bullish breakout potential.
Fibonacci Pivot Point	$512.46	Buy	Price ($523.44) has broken above resistance R1 ($519.45) — bullish breakout potential.
Exponential Moving Averages	$484.57 - $504.22(5 indicators)	Buy	EMA group: 5/5 bullish, 0 bearish, 0 neutral. Price above key EMA averages.
Simple Moving Averages	$473.40 - $526.47(5 indicators)	Buy	SMA group: 4/5 bullish, 1 bearish, 0 neutral. Price above key SMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

The day wrapped with TMO preserving a mild 1.96% upside gap. The session finished with relatively light trading in TMO, at 0.66× its average volume. TMO edges higher after Arcturus' Thermo Fisher collaboration, underscoring Thermo Fisher's Accelerator Drug Development capabilities.

Trading Volume

vs S&P 500 Today

Strong Outperformance

+10.39%

52-Week Position

Mid-range

49.9%

Updated: July 2, 2026 at 20:07 UTC